ADARB2 and breast cancer: Dysregulation of the lncRNA DSCR8 has been observed in uterine cancer, melanoma and liver cancer [34], and upregulation of ADARB2-AS1 has been detected in human epidermal growth factor receptor 2-positive BC [35].